Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3093)
All Articles published online
|
Publishing Process of This Article
|
Sep 25, 2022 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Spera AM. Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment. World J Virol 2022; 11(5): 275-282 [PMID: 36188738 DOI: 10.5501/wjv.v11.i5.275] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v11/i5/275.htm |
| Number | Citing Articles |
| 1 |
Derya Çırakoğlu, Emine Serap Yılmaz. Prevalence of Hepatitis B Serology and Reactivation in Rheumatology Patients Receiving Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs. Medical Records 2024; 6(3): 542 doi: 10.37990/medr.1530674
|
| 2 |
Emilia Lazarou, Christos Koutsianas, Panayotis K. Vlachakis, Panagiotis Theofilis, Dimitrios Vassilopoulos, Costas Tsioufis, George Lazaros, Dimitris Tousoulis. Novel Treatments in Refractory Recurrent Pericarditis. Pharmaceuticals 2024; 17(8): 1069 doi: 10.3390/ph17081069
|
| 3 |
Nicole M. Hahn, Lara W. Katzin. Assessing hepatitis B virus serologies when transitioning patients from intravenous immune globulin therapy to rituximab for the treatment of autoimmune neuromuscular diseases. Muscle & Nerve 2024; 70(5): 1040 doi: 10.1002/mus.28253
|
| 4 |
Emilia Lazarou, Christos Koutsianas, Panagiotis Theofilis, George Lazaros, Dimitrios Vassilopoulos, Charalambos Vlachopoulos, Costas Tsioufis, Massimo Imazio, Antonio Brucato, Dimitris Tousoulis. Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis. Life 2024; 14(3): 305 doi: 10.3390/life14030305
|
| 5 |
Nicoleta Mihai, Mihaela Cristina Olariu, Oana-Alexandra Ganea, Aida-Isabela Adamescu, Violeta Molagic, Ștefan Sorin Aramă, Cătălin Tilișcan, Victoria Aramă. Risk of Hepatitis B Virus Reactivation in COVID-19 Patients Receiving Immunosuppressive Treatment: A Prospective Study. Journal of Clinical Medicine 2024; 13(20): 6032 doi: 10.3390/jcm13206032
|
| 6 |
Ali Mussa, Nor Hayati Ismail, Nazmul Huda Syed, Mustafa Talib, Alaa Siddig, Rosline Hassan, Rohimah Mohamud, Nik Haszroel Hysham Nik Hashim. Immune response to occult hepatitis B virus infection among hemodialysis patients: A review. The Microbe 2024; 5: 100176 doi: 10.1016/j.microb.2024.100176
|
| 7 |
Ioannis Braimakis, Sofia Vasileiadi, Eleni-Myrto Trifylli, Nikolaos Papadopoulos, Melanie Deutsch. Can Hepatitis B Virus (HBV) Reactivation Result from a Mild COVID-19 Infection?. Livers 2023; 3(3): 347 doi: 10.3390/livers3030026
|
| 8 |
Na Wei, Bin Zheng, Hongfu Cai, Na Li, Jing Yang, Maobai Liu. Systematic review and meta-analysis: de novo combination of nucleos(t)ide analogs and pegylated interferon alpha versus pegylated interferon alpha monotherapy for the functional cure of chronic hepatitis B. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1403805
|
| 9 |
Galina I. Gridneva, Boris S. Belov, Evgeniia S. Aronova. Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review. Terapevticheskii arkhiv 2024; 96(5): 523 doi: 10.26442/00403660.2024.05.202707
|